A Phase 1, Single-Center, Open-Label, Induction Dose Study of ABP-700 in Healthy, Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 13 Oct 2016
At a glance
- Drugs Fentanyl (Primary) ; MDCO 700 (Primary) ; Midazolam (Primary)
- Indications Anaesthesia
- Focus Adverse reactions
- Sponsors The Medicines Company
- 13 Oct 2016 According to The Medicines Company media release, data from this trial will be presented at the International Society for Anaesthetic Pharmacology 25th Annual Meeting (ISAP) 2016.
- 14 Jun 2016 Status changed from recruiting to completed, according to The Medicines Company media release.
- 24 Nov 2015 New trial record